Back
Protagonist Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$81.51
Seasonality Move:
6.39%
7 Day Trial
ALL ACCESS PASS
$
7
Protagonist Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 40.4% based on the past 9 years of stock performance.
-
Protagonist Therapeutics, Inc. has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
-
Is Protagonist Therapeutics, Inc. Stock Undervalued?The current Protagonist Therapeutics, Inc. [PTGX] share price is $81.93. The Score for PTGX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 40.4% based on the past 9 years of stock performance.
Protagonist Therapeutics, Inc. Stock Rating
Sell
35
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Is Protagonist Therapeutics, Inc. overpriced?
-
Protagonist Therapeutics, Inc. has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Protagonist Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
96.54
52-Week Low:
33.70
Prediction Charts
Market Cap:
5.1B
Price in USD:
81.93
Volume:
352.5K
Beta:
1.93
Technical Analysis
SMA50:
85.46
SMA100:
81.01
SMA200:
67.01
52-Wk Change:
118.95%
Stock Predictions
-
Is Protagonist Therapeutics, Inc. stock public?Yes, Protagonist Therapeutics, Inc. is a publicly traded company.
-
What is the Protagonist Therapeutics, Inc. stock quote today?The Protagonist Therapeutics, Inc. stock price is 81.93 USD today.
-
How to buy Protagonist Therapeutics, Inc. stock online?You can buy Protagonist Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-26 | 82.53 | 82.30 | 84.32 | 81.94 |
| Jan-27 | 82.00 | 83.08 | 83.87 | 82.00 |
| Jan-28 | 82.45 | 81.76 | 83.69 | 80.00 |
| Jan-29 | 81.39 | 79.73 | 82.49 | 77.70 |
| Jan-30 | 79.77 | 81.80 | 82.56 | 78.75 |
| Feb-2 | 81.80 | 83.05 | 84.55 | 81.14 |
| Feb-3 | 83.09 | 85.59 | 86.10 | 82.88 |
| Feb-4 | 85.59 | 83.30 | 85.60 | 81.00 |
| Feb-5 | 83.62 | 80.67 | 85.43 | 80.20 |
| Feb-6 | 82.11 | 84.49 | 85.05 | 81.55 |
| Feb-9 | 83.47 | 83.32 | 83.90 | 82.21 |
| Feb-10 | 83.00 | 83.88 | 84.90 | 82.65 |
| Feb-11 | 83.46 | 83.49 | 84.82 | 80.99 |
| Feb-12 | 84.07 | 81.93 | 84.72 | 81.56 |
Protagonist Therapeutics, Inc. Earnings
Protagonist Therapeutics, Inc. Earnings Report: Per Share Protagonist Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics, Inc. Forecast Revenue Growth
Protagonist Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.44 per share, and a decrease next year of $2.52 per share.
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.